MGM
ADMA icon

Miura Global Management’s ADMA Biologics ADMA Stock Holding History

Miura Global Management’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-50,000
Closed -$858K – 22
2024
Q4 		$858K Buy
50,000
+10,000
+25% +$188K 0.94% 26
2024
Q3 		$800K Sell
40,000
-260,000
-87% -$4.04M 0.92% 19
2024
Q2 		$3.35M Buy
+300,000
New +$2.52M 3.27% 14

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

Miura Global Management's ADMA Position: Q1 2025 in Review

Miura Global Management sold out of ADMA Biologics (ADMA) in Q1 2025, closing a stake of 50,000 shares — an estimated $858K sold.

Miura Global Management first reported a position in ADMA in Q2 2024 and held it in 3 quarters. The position peaked at $3.35M in Q2 2024. 346 funds tracked by Wall St. Rank hold ADMA as of Q1 2025.

  • Miura Global Management reported no remaining ADMA Biologics position as of Q1 2025 after selling out during the quarter.
  • Miura Global Management sold 50,000 ADMA Biologics shares in Q1 2025, an estimated $858K.
  • Miura Global Management first reported a position in ADMA Biologics in Q2 2024 and held it in 3 quarters.
  • Miura Global Management's ADMA Biologics position peaked at $3.35M in Q2 2024.
  • 346 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2025.

Based on Miura Global Management's 13F filing for Q1 2025, filed 15 May 2025.